WNS (HOLDINGS) LTD | CIK:0001356570 | 3

  • Filed: 5/16/2018
  • Entity registrant name: WNS (HOLDINGS) LTD (CIK: 0001356570)
  • Generator: Donnelley Financial Solutions
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1356570/000119312518165444/0001193125-18-165444-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1356570/000119312518165444/wns-20180331.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001356570
  • Open this page in separate window: Click
  • ifrs-full:DisclosureOfBusinessCombinationsExplanatory

    4. Business Combinations

    a) HealthHelp

    On March 15, 2017 (“Acquisition date”), the Company acquired all ownership interests of MTS HealthHelp Inc. and its subsidiaries (“HealthHelp”), which provides benefits management across several specialty healthcare areas, including radiology, cardiology, oncology, sleep care, orthopedics, and pain management, for a total consideration of $68,910, including working capital adjustments of $573 and a contingent consideration of $8,545, payable over a period of two years linked to revenue targets and continuation of an identified client contract. The fair value of the contingent consideration liability was estimated using level 3 inputs which included an assumption for discount rate of 2.5%. The potential undiscounted amount of all future payments that the Company could be required to make under the contingent consideration arrangement is between $0 and $8,876.

    The Company funded the acquisition primarily with a five year secured term loan. The Company is expected to leverage HealthHelp’s capability in care management to address the needs of payor, provider and insurance organizations.

    The Company incurred acquisition related costs of $1,809, which have been included in “General and administrative expenses” in the consolidated statement of income for the year ended March 31, 2017.

    During the year ended March 31, 2018, the Company made a payment of $573 towards working capital adjustments.

    In March 2018, a contingent consideration of $3,114 was paid by the Company to the sellers on achievement of the revenue target in relation to the identified client contract related to the first measurement period and an amount of $1,324 was reversed and credited to its consolidated income statement, due to the shortfall in revenue target achievement for the identified client contract, in accordance with the terms of the share purchase agreement (“SPA”).

    The purchase price has been allocated, as set out below, to the assets acquired and liabilities assumed in the business combination.

     

         Amount  

    Cash

       $ 3,119  

    Trade receivables

         4,910  

    Unbilled revenue

         2,016  

    Prepayments and other current assets

         1,060  

    Property and equipment

         4,612  

    Intangible assets

      

    - Software

         1,274  

    - Customer contracts

         4,537  

    - Customer relationships

         49,584  

    - Service mark

         400  

    - Covenant not-to-compete

         4,693  

    - Technology

         4,852  

    Non-current assets

         161  

    Term loan

         (29,249

    Current liabilities

         (2,555

    Non-current liabilities

         (1,423

    Deferred tax liability

         (18,163
      

     

     

     

    Net assets acquired

       $ 29,828  

    Less: Purchase consideration

         68,910  
      

     

     

     

    Goodwill on acquisition

       $ 39,082  
      

     

     

     

    Goodwill of $14,876 arising from this acquisition is expected to be deductible for tax purposes. Goodwill is attributable mainly to expected synergies and assembled workforce arising from the acquisition.

    During the year ended March 31, 2018, the Company has completed the accounting of the assets acquired and liabilities assumed on acquisition. Corresponding changes to the comparatives for the year ended March 31, 2017 have not been made, as the impact of the change on finalization of purchase price allocation is not material to the Company’s statement of financial position or statement of income.

     

    b) Denali Sourcing Services Inc.

    On January 20, 2017 (“Acquisition Date”), the Company acquired all outstanding shares of Denali Sourcing Services Inc. (“Denali”), a provider of strategic procurement BPM solutions for a purchase consideration of $38,668 (including the contingent consideration of $6,277, dependent on the achievement of revenue targets over a period of three years and deferred consideration of $522 payable in first quarter of fiscal 2018), including adjustments for working capital. The fair value of the contingent consideration liability was estimated using Level 3 inputs which included an assumption for discount rate of 2.5%. The potential undiscounted amount of all future payments that the Company could be required to make under the contingent consideration arrangement is between $0 and $6,578. The payment was funded through a three-year secured term loan.

    Denali delivers global sourcing and procurement services to high-tech, retail and Consumer Packaged Goods (“CPG”), banking and financial services, utilities, and healthcare verticals. The acquisition of Denali is expected to add a strategic procurement capability to the Company’s existing Finance and Accounting services and will enable the Company to offer procurement solutions to its clients.

    The Company incurred acquisition related costs of $502, which have been included in “General and administrative expenses” in the consolidated statement of income for the year ended March 31, 2017.

    During the year ended March 31, 2018, the Company made payment of $522 towards deferred consideration and an amount of $968 was reduced from the purchase consideration towards working capital adjustments.

    In January 2018, a contingent consideration of $2,351 was paid by the Company to the sellers on achievement of the revenue target related to the first measurement period.

    The purchase price has been allocated, as set out below, to the assets acquired and liabilities assumed in the business combination.

     

         Amount  

    Cash

       $ 1,204  

    Trade receivables

         2,799  

    Unbilled revenue

         1,258  

    Prepayments and other current assets

         95  

    Property and equipment

         53  

    Deferred tax asset

         18  

    Intangible assets

      

    - Software

         3  

    - Customer contracts

         3,025  

    - Customer relationships

         8,000  

    - Trade name

         545  

    - Covenant not-to-compete

         1,718  

    Non-current assets

         27  

    Current liabilities

         (3,781

    Short-term line of credit

         (475

    Non-current liabilities

         (343

    Deferred tax liability

         (5,020
      

     

     

     

    Net assets acquired

       $ 9,126  

    Less: Purchase consideration

         38,668  
      

     

     

     

    Goodwill on acquisition

       $ 29,542  
      

     

     

     

     

    Goodwill arising from this acquisition is not expected to be deductible for tax purposes. Goodwill is attributable mainly to expected synergies and assembled workforce arising from the acquisition.

    During the year ended March 31, 2018, the Company has completed the accounting of the assets acquired and liabilities assumed on acquisition. Corresponding changes to the comparatives for the year ended March 31, 2017 have not been made, as the impact of the change on finalization of purchase price allocation is not material to the Company’s statement of financial position or statement of income.

    c) Value Edge

    On June 14, 2016 (“Acquisition Date”), the Company acquired all outstanding equity shares of Value Edge Research Services Private Limited (“Value Edge”) which provides business research and analytics reports and databases across the domains of pharmaceutical, biotech and medical devices, for a total consideration of $18,265 including working capital adjustments of $765 and contingent consideration of $5,112 (held in escrow), subject to compliance with certain conditions, payable over a period of three years. The acquisition is expected to deepen the Company’s domain and specialized analytical capabilities in the growing pharma market, and provide the Company with a technology asset, which is leverageable across clients and industries.

    The Company incurred acquisition related costs of $24, which have been included in “General and administrative expenses” in the consolidated statement of income for the year ended March 31, 2017.

    During the year ended March 31, 2018, the Company released from escrow an amount of $1,535 towards contingent consideration to the sellers.

    The purchase price has been allocated, as set out below, to the assets acquired and liabilities assumed in the business combination.

     

         Amount  

    Cash

       $ 432  

    Trade receivables

         370  

    Unbilled revenue

         706  

    Investments

         87  

    Prepayments and other current assets

         99  

    Property and equipment

         78  

    Deferred tax asset

         49  

    Intangible assets

      

    - Software

         10  

    - Customer contracts

         701  

    - Customer relationships

         1,894  

    - Trade name

         104  

    - Covenant not-to-compete

         2,655  

    - Technology

         1,238  

    Non-current assets

         74  

    Current liabilities

         (1,236

    Non-current liabilities

         (126

    Deferred tax liability

         (2,281
      

     

     

     

    Net assets acquired

       $ 4,854  

    Less: Purchase consideration

         18,265  
      

     

     

     

    Goodwill on acquisition

       $ 13,411  
      

     

     

     

     

    Goodwill arising from this acquisition is not expected to be deductible for tax purposes (Refer Note 23). Goodwill is attributable mainly to expected synergies and assembled workforce arising from the acquisition.

     

    d) Telkom

    On April 10, 2015, the Company entered into an agreement with Telkom SA SOC LIMITED (“Telkom”), a leading provider of communication services in South Africa, pursuant to which the Company agreed to acquire a contract and the related workforce of Telkom effective May 1, 2015 (“Acquisition Date”). The net purchase price of the transaction, which was paid in cash, was ZAR 35,639 ($2,572 based on the exchange rate on September 30, 2015).

    The purchase price has been allocated as follows:

     

         Amount  

    Customer contract- intangible assets

       $ 2,990  

    Cash

         411  

    Accrued leave liability

         (411

    Deferred tax liabilities

         (837
      

     

     

     

    Net assets acquired

       $ 2,153  

    Less: Purchase consideration

         3,331  
      

     

     

     

    Goodwill on acquisition

       $ 1,178  
      

     

     

     

    Goodwill arising from this acquisition is not expected to be deductible for tax purposes. Goodwill is attributable mainly to benefit from expected synergies and the assembled workforce of Telkom.